Pathogenesis of vascular dementia: the possible role of hypertension

B B Johansson1

  • 1Department of Neurology, Lund University Hospital, Sweden.

Dementia (Basel, Switzerland)
|May 1, 1994
PubMed

Insights

Hypertension significantly increases the risk of cerebrovascular disease and may contribute to vascular dementia. Further prospective studies are needed to clarify the role of high blood pressure in silent white matter hyperintensities.

Area of Science:

  • Neurology
  • Cardiology
  • Gerontology

Background:

  • Hypertension is a primary risk factor for cerebrovascular disease.
  • The precise role of hypertension in vascular dementia remains unclear despite existing research.
  • Hypertension can lead to arterial changes, potentially causing cerebrovascular events.

Purpose of the Study:

  • To investigate the association between hypertension and silent white matter hyperintensities (WMHIs).
  • To evaluate the impact of hypertension on cerebrovascular health and its potential link to vascular dementia.

Main Methods:

  • Analysis of retrospective data on hypertension and cerebrovascular disease.
  • Review of magnetic resonance imaging findings related to WMHIs in different blood pressure groups.
  • Comparison of WMHI prevalence in normotensive versus hypertensive individuals across age groups.

Main Results:

  • WMHIs are uncommon in normotensive individuals under 55.
  • WMHIs become more frequent in individuals with moderate to marked hypertension.
  • The study presents data suggesting a link between hypertension and WMHIs.

Conclusions:

  • Hypertension is implicated in the development of WMHIs.
  • Prospective studies are recommended to further elucidate the role of hypertension in vascular dementia.
  • Understanding hypertension's impact on cerebrovascular changes is crucial for dementia prevention.

Related Concept Videos

Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Cerebral Edema ll: Pathophysiology01:22

Cerebral Edema ll: Pathophysiology

Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...